Incidence of recurrent venous thromboembolism of patients after termination of treatment with ximelagatran
Recurrent thromboembolic events may occur after termination of anticoagulant therapy for acute venous thromboembolism (VTE) using oral direct thrombin inhibitor ximelagatran.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
4 January 2006
|
| In: |
European journal of clinical pharmacology
Year: 2006, Volume: 62, Issue: 3, Pages: 173-177 |
| ISSN: | 1432-1041 |
| DOI: | 10.1007/s00228-005-0076-9 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00228-005-0076-9
|
| Author Notes: | Job Harenberg, Ingrid Jörg, Christel Weiss |
| Summary: | Recurrent thromboembolic events may occur after termination of anticoagulant therapy for acute venous thromboembolism (VTE) using oral direct thrombin inhibitor ximelagatran. |
|---|---|
| Item Description: | Gesehen am 14.04.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1432-1041 |
| DOI: | 10.1007/s00228-005-0076-9 |